Whiteside S, Markova M, Chin A, Lam C, Dharmani-Khan P, Modi M, Khan FM, Storek J: Influence of Chemotherapy on Allergen-Specific IgE. Int Arch Allergy Immunol. 2018: 177(2): doi: 10.1159/000489706 Jun 26.
Dabas R, Dharmani-Khan P, Modi M, van Slyke T, Luider J, Morris D, Brandwein J, Daly A, Khan FM, Storek J. Anti-thymocyte globulin’s activity against acute myeloid leukemia stem cells. Bone Marro Transplantation. 2018 Aug 14. 10.1038/S41409-018-0296-0
Whiteside S, Markova M, Chin A, Lam C, Dharmani-Khan P, Modi M, Khan FM, Storek J. Influence of Chemotherapy on Allergen-Specific IgE. Int Arch Allergy Immunol. 2018; 177(2):145-152.
Kalra A, Roessner C, Jupp J, Williamson T, Tellier R, Chaudhry A, Khan FM, Taparia M, Jimenez-Zepeda VH, Stewart DA, Daly A, Storek J. Epstein-barr virus DNAemia monitoring for the management of post-transplant lymphoproliferative disorder. Cytotherapy. 2018;20(5):706-714.
Kalra A, Roessner C, Jupp J, Williamson T, Tellier R, Chaudhry A, Khan FM, Taparia M, Jimenez-Zepeda VH, Stewart DA, Daly A, Storek J. Risk factors for post-transplant lymphoproliferative disorder after Thymoglobulin-conditioned hematopoietic cell transplantation. Clin Transplant. 2018;32(1).
Mostafa AA, Petrosenko M, Stamm L, Khan FM, Berka N. A novel HLA-A*26 allele, HLA-A*26:01:44, identified in a Caucasian individual. HLA. 2018 ;91(2):127-128.
Mostafa AA, Petrosenko M, Stamm L, Khan FM, Berka N. The novel HLA-B*08:183 allele identified by sequence-based typing in a Caucasian leukemia patient. HLA. 2017;90(6):367-368.
Mostafa AA, Khan FM, Stamm L, Petrosenko M, Berka N. HLA-DQB1*05:144, a novel allele, discovered in a Southeast Asian donor for stem cell transplantation. HLA. 2017;90(3):182-183.
Sidahmed AM, Anderson J, Stamm L, Khan FM, Berka N. HLA-A23:01:19, a novel variant of HLA-A23:01, discovered in a West African stem cell transplantation patient. HLA. 2016;88(3):120-1.
Kalra A, Williamson T, Daly A, Savoie ML, Stewart DA, Khan FM, Storek J. Impact of Donor and Recipient Cytomegalovirus Serostatus on Outcomes of Antithymocyte Globulin-Conditioned Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2016;22(9):1654-63.
Faridi RM, Kemp TJ, Dharmani-Khan P, Lewis V, Tripathi G, Rajalingam R, Daly A, Berka N, Storek J, Khan FM. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation. PLoS One.2016;11(6):e0158242.
Dabas R, Lee R, Servito MT, Dharmani-Khan P, Modi M, Van Slyke T, Luider J, Durand C, Larratt L, Brandwein J, Daly A, Khan FM, Storek J. Antithymocyte Globulin at Clinically Relevant Concentrations Kills Leukemic Blasts. Biol Blood Marrow Transplant. 2016;22(5):815-24
Podgorny PJ, Pratt LM, Liu Y, Dharmani-Khan P, Luider J, Auer-Grzesiak I, Mansoor A, Williamson TS, Ugarte-Torres A, Hoegh-Petersen M, Khan FM, Larratt L, Jimenez-Zepeda VH, Stewart DA, Russell JA, Daly A, Storek J. Low Counts of B Cells, Natural Killer Cells, Monocytes, Dendritic Cells, Basophils, and Eosinophils are Associated with Post engraftment Infections after Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2016; 2016;22(1):37-46
Wang J, Kostur C, Stamm L, Khan FM, Berka N. Identification of the novel allele, HLA-B*27:131. Tissue Antigens. 2015;85(2):142-4.
Chawla S, Dharmani-Khan P, Liu Y, Munir M, Griffith C, Khan FM, Russel JA, Daly A, Storek J. High serum level of antithymocyte globulin immediately before graft infusion is associated with a low likelihood of chronic but not acute graft-vs-host disease. Biol Blood Marrow Transplant 2014; 20(8):1156-62.
Podgorny PJ, Liu Y, Dharmani-Khan P, Pratt LM, Jamani K, Luider J, Auer-Grzesiak I, Mansoor A, Williamson TS, Ugarte-Torres A, Hoegh-Petersen M, Stewart DA, Daly A, Khan FM, Russell JA, Storek J. Immune cell subset counts associated with graft-vs-host disease. Biol Blood Marrow Transplant 2014: 20(4):450-62
Pratt LM, Liu Y, Ugarte-Torres A, Hoegh-Petersen M, Podgorny PJ, Lyon AW, Williamson TS, Khan FM, Chaudhry MA, Daly A, Stewart DA, Russell JA, Grigg A, Ritchie D, Storek J. Interleukin-15 levels on day 7 after hematopoietic cell transplantation predict chronic graft-versus-host disease. BMT 2013:48:772-728